Search

Russell Condie Phones & Addresses

  • 1709 2410 S, Saint George, UT 84790 (435) 673-7035
  • 156 500 S, Saint George, UT 84770 (435) 673-7035
  • St George, UT
  • Herriman, UT
  • Cedar City, UT

Work

Position: Clerical/White Collar

Education

Degree: Graduate or professional degree

Resumes

Resumes

Russell Condie Photo 1

Owner, Myophysix Massage And Bodywork Co

View page
Location:
Greater Salt Lake City Area
Industry:
Health, Wellness and Fitness
Russell Condie Photo 2

Staff Engineer

View page
Location:
Saint George, UT
Industry:
Utilities
Work:
Dixie Power
Staff Engineer
Education:
Southern Utah University 1989 - 2008
Bachelor of Applied Science, Bachelors, Engineering
Dixie State University 2004 - 2006
Dixie State University 1990 - 1992
Associates, Engineering
Russell Condie Photo 3

Assistant City Treasurer At West Valley City

View page
Position:
Assistant City Treasurer at West Valley City
Location:
Greater Salt Lake City Area
Industry:
Government Administration
Work:
West Valley City
Assistant City Treasurer

Publications

Us Patents

Stable Perfluorocarbon Emulsion For Use As An Artificial Oxygen Carrier

View page
US Patent:
20110306581, Dec 15, 2011
Filed:
Dec 8, 2009
Appl. No.:
13/133126
Inventors:
Natalya Y. Rapoport - Sandy UT, US
Glenn D. Prestwich - Eastsound WA, US
Russell Morris Condie - Salt Lake City UT, US
Assignee:
University of Utah Research Foundation - Salt Lake City UT
International Classification:
A61K 31/56
A61K 31/02
A61K 31/025
A61P 39/04
A61P 7/00
A61P 7/02
A61P 39/06
A61K 31/357
C12N 5/071
US Classification:
514171, 514450, 514759, 514761, 514747, 435375
Abstract:
Perfluorocarbon emulsions having a high stability and good oxygen release are disclosed and described. These perfluorocarbon emulsions are typically for use as artificial oxygen carriers. The perfluorocarbon emulsions include a disperse phase of a perfluorocarbon and an emulsion stabilizer, and continuous phase. The emulsion stabilizer can primarily include a poly(ethylene oxide) block copolymer. These stabilized perfluorocarbon emulsions can be used in liquid and/or hydrogel phases of perfusion bioreactors or various other culture systems to enhance cell viability in thick tissue constructs, or as blood substitutes, although other applications may also be considered.

Methods For Diagnosing And Monitoring Eosinophilic Esophagitis

View page
US Patent:
20200016282, Jan 16, 2020
Filed:
Jul 3, 2019
Appl. No.:
16/502328
Inventors:
- Salt Lake City UT, US
Hedieh Saffari - Salt Lake City UT, US
Gerald J. Gleich - Salt Lake City UT, US
Kristin M. Leiferman - Salt Lake City UT, US
Kathryn A. Peterson - Salt Lake City UT, US
Russell Morris Condie - Salt Lake City UT, US
International Classification:
A61K 51/04
A61K 51/08
Abstract:
Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment. In another aspect, disclosed is a method of diagnosing eosinophilic esophagitis or eosinophilic diseases in a subject, comprising detecting an eosinophil granule protein in the mucosal tissue of the esophagus or other organs in a subject.

Methods For Diagnosing And Monitoring Eosinophilic Esophagitis

View page
US Patent:
20180036440, Feb 8, 2018
Filed:
Sep 29, 2017
Appl. No.:
15/719827
Inventors:
- Salt Lake City UT, US
Hedieh Saffari - Salt Lake City UT, US
Gerald J. Gleich - Salt Lake City UT, US
Kristin M. Leiferman - Salt Lake City UT, US
Kathryn A. Peterson - Salt Lake City UT, US
Russell Morris Condie - Salt Lake City UT, US
International Classification:
A61K 51/04
A61K 51/08
Abstract:
Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment. In another aspect, disclosed is a method of diagnosing eosinophilic esophagitis or eosinophilic diseases in a subject, comprising detecting an eosinophil granule protein in the mucosal tissue of the esophagitis or other organs in a subject.

Methods For Diagnosing And Monitoring Eosinophilic Esophagitis

View page
US Patent:
20150132221, May 14, 2015
Filed:
May 17, 2013
Appl. No.:
14/402070
Inventors:
- Salt Lake City UT, US
Hedieh Saffari - Salt Lake City UT, US
Gerald J. Gleich - Salt Lake City UT, US
Kristin M. Leiferman - Salt Lake City UT, US
Kathryn A. Peterson - Salt Lake City UT, US
Russell Morris Condie - Salt Lake City UT, US
International Classification:
A61K 51/04
US Classification:
424 173
Abstract:
Disclosed are compositions and methods for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for monitoring the course of eosinophilic esophagitis in a subject before, during, and after treatment.

Novel Echogenic Contrast Agents

View page
US Patent:
20150132227, May 14, 2015
Filed:
Apr 18, 2013
Appl. No.:
14/395407
Inventors:
- Salt Lake City UT, US
Hedieh Saffari - Salt Lake City UT, US
Kathryn Peterson - Salt Lake City UT, US
Kristin Leiferman - Salt Lake City UT, US
Anne Kennedy - Salt Lake City UT, US
Russell Morris Condie - Salt Lake City UT, US
Gerald Gleich - Salt Lake City UT, US
International Classification:
A61K 49/22
US Classification:
424 95, 5303913
Abstract:
Disclosed are compositions and methods for related to echogenic contrast agents. Also disclosed are methods and compositions for diagnosing eosinophilic esophagitis in a subject. Also disclosed are methods for producing a medical image of a tissue. Also disclosed are methods of monitoring the progression of eosinophilic esophagitis in a subject before, during, and after treatment.
Russell Condie from Saint George, UT, age ~57 Get Report